IN2014MN02338A - - Google Patents
Info
- Publication number
- IN2014MN02338A IN2014MN02338A IN2338MUN2014A IN2014MN02338A IN 2014MN02338 A IN2014MN02338 A IN 2014MN02338A IN 2338MUN2014 A IN2338MUN2014 A IN 2338MUN2014A IN 2014MN02338 A IN2014MN02338 A IN 2014MN02338A
- Authority
- IN
- India
- Prior art keywords
- inhibitors
- relates
- present
- tec
- members
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2779184A CA2779184A1 (en) | 2012-05-31 | 2012-05-31 | Protein kinase inhibitors |
CA2813299A CA2813299A1 (en) | 2013-04-17 | 2013-04-17 | Protein kinase inhibitors |
PCT/CA2013/000513 WO2013177668A1 (en) | 2012-05-31 | 2013-05-28 | Protein kinase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014MN02338A true IN2014MN02338A (tr) | 2015-08-14 |
Family
ID=49672221
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN2338MUN2014 IN2014MN02338A (tr) | 2012-05-31 | 2013-05-28 |
Country Status (11)
Country | Link |
---|---|
US (1) | US9796716B2 (tr) |
EP (1) | EP2855484A4 (tr) |
JP (1) | JP6175495B2 (tr) |
KR (2) | KR101972990B1 (tr) |
CN (1) | CN104379586B (tr) |
BR (1) | BR112014029718A2 (tr) |
CA (1) | CA2874211A1 (tr) |
HK (1) | HK1208460A1 (tr) |
IN (1) | IN2014MN02338A (tr) |
RU (1) | RU2678767C2 (tr) |
WO (1) | WO2013177668A1 (tr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2833867A1 (en) * | 2013-11-21 | 2015-05-21 | Pharmascience Inc. | Protein kinase inhibitors |
CA2834528A1 (en) * | 2013-11-26 | 2015-05-26 | Pharmascience Inc. | Protein kinase inhibitors |
CA2953798C (en) * | 2014-07-07 | 2019-06-11 | Eternity Bioscience Inc. | Aminopyridazinone compounds as protein kinase inhibitors |
GB201508747D0 (en) * | 2015-05-21 | 2015-07-01 | Univ Edinburgh | Compounds |
CA3025813A1 (en) * | 2015-05-27 | 2016-12-01 | Gb005, Inc. | Inhibitors of the tec kinase enzyme family |
US10927087B2 (en) | 2015-12-07 | 2021-02-23 | Dic Corporation | Method for producing polymerizable compound |
WO2017134685A2 (en) * | 2016-02-02 | 2017-08-10 | Sun Pharma Advanced Research Company Limited | Novel hydrazino compounds as btk inhibitors |
CN109369654A (zh) * | 2018-11-20 | 2019-02-22 | 山东大学 | 1,3-二取代-4-氨基吡唑并嘧啶类化合物及其制备方法和应用 |
CN111454268B (zh) * | 2019-01-18 | 2023-09-08 | 明慧医药(上海)有限公司 | 作为布鲁顿酪氨酸激酶抑制剂的环状分子 |
WO2023083373A1 (zh) * | 2021-11-15 | 2023-05-19 | 微境生物医药科技(上海)有限公司 | 作为Src抑制剂的化合物 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1390219A (zh) * | 1999-09-17 | 2003-01-08 | 艾博特股份有限两合公司 | 作为治疗剂的吡唑并嘧啶类 |
US6921763B2 (en) * | 1999-09-17 | 2005-07-26 | Abbott Laboratories | Pyrazolopyrimidines as therapeutic agents |
KR20020063854A (ko) | 1999-09-17 | 2002-08-05 | 애보트 게엠베하 운트 콤파니 카게 | 치료제로서의 키나제 억제제 |
SK13752001A3 (sk) * | 1999-12-27 | 2002-07-02 | Japan Tobacco, Inc. | Zlúčeniny s fúzovanými kruhmi a ich použitie ako liečiv |
AUPR392301A0 (en) | 2001-03-23 | 2001-04-26 | University Of Newcastle Research Associates Limited, The | Protein phosphatase inhibitors |
CA2450777C (en) * | 2001-08-10 | 2013-04-09 | Novartis Ag | Use of c-src inhibitors alone or in combination with sti571 for the treatment of leukaemia |
LT2530083T (lt) * | 2006-09-22 | 2016-09-26 | Pharmacyclics Llc | Brutono tirozinkinazės inhibitoriai |
EP2561875A3 (en) * | 2007-03-28 | 2013-06-12 | Pharmacyclics, Inc. | Inhibitors of bruton's tyrosine kinase |
US7718662B1 (en) * | 2009-10-12 | 2010-05-18 | Pharmacyclics, Inc. | Pyrazolo-pyrimidine inhibitors of bruton's tyrosine kinase |
AU2010307006B2 (en) * | 2009-10-13 | 2016-08-11 | Ligand Pharmaceuticals Inc. | Hematopoietic growth factor mimetic small molecule compounds and their uses |
JP6139782B2 (ja) * | 2013-05-21 | 2017-05-31 | チャンスー メドリューション リミテッド | 置換ピラゾロピリミジン化合物、及びその薬学的に許容される塩、並びにこれらの溶媒和物、立体異性体、及び互変異性体、並びにこれらを含む医薬組成物 |
CN103787839B (zh) | 2014-01-21 | 2015-12-02 | 苏州昊帆生物科技有限公司 | 合成2,3,4,5,6-五氟苯酚的方法 |
-
2013
- 2013-05-28 BR BR112014029718A patent/BR112014029718A2/pt not_active Application Discontinuation
- 2013-05-28 CN CN201380028248.2A patent/CN104379586B/zh not_active Expired - Fee Related
- 2013-05-28 IN IN2338MUN2014 patent/IN2014MN02338A/en unknown
- 2013-05-28 EP EP13796590.1A patent/EP2855484A4/en not_active Withdrawn
- 2013-05-28 RU RU2014145285A patent/RU2678767C2/ru not_active IP Right Cessation
- 2013-05-28 KR KR1020147036372A patent/KR101972990B1/ko active IP Right Grant
- 2013-05-28 WO PCT/CA2013/000513 patent/WO2013177668A1/en active Application Filing
- 2013-05-28 JP JP2015514295A patent/JP6175495B2/ja not_active Expired - Fee Related
- 2013-05-28 CA CA2874211A patent/CA2874211A1/en not_active Abandoned
- 2013-05-28 US US14/404,497 patent/US9796716B2/en not_active Expired - Fee Related
- 2013-05-28 KR KR1020197011438A patent/KR20190043648A/ko not_active Application Discontinuation
-
2015
- 2015-09-18 HK HK15109229.7A patent/HK1208460A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
EP2855484A4 (en) | 2015-12-16 |
JP6175495B2 (ja) | 2017-08-02 |
CN104379586B (zh) | 2018-01-16 |
WO2013177668A1 (en) | 2013-12-05 |
US9796716B2 (en) | 2017-10-24 |
KR20150015527A (ko) | 2015-02-10 |
KR101972990B1 (ko) | 2019-04-26 |
HK1208460A1 (en) | 2016-03-04 |
US20150191473A1 (en) | 2015-07-09 |
JP2015518009A (ja) | 2015-06-25 |
EP2855484A1 (en) | 2015-04-08 |
CA2874211A1 (en) | 2013-12-05 |
CN104379586A (zh) | 2015-02-25 |
KR20190043648A (ko) | 2019-04-26 |
BR112014029718A2 (pt) | 2017-06-27 |
RU2014145285A (ru) | 2016-07-20 |
RU2678767C2 (ru) | 2019-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2014MN02338A (tr) | ||
HK1210471A1 (en) | Novel pyrrolopyrimidine compounds as inhibitors of protein kinases | |
HK1206298A1 (en) | Compounds useful as inhibitors of atr kinase and combination therapies thereof atr | |
HK1215577A1 (zh) | 蛋白激酶抑制劑 | |
HK1212336A1 (en) | Azaquinazoline inhibitors of atypical protein kinase | |
ZA201405140B (en) | Disubstituted benzothienyl-pyrolotriazines and their use as fgfr kinase inhibitors | |
MX355728B (es) | Inhibidores de cinasas. | |
HK1202333A1 (en) | Combination of kinase inhibitors and uses thereof | |
MX2013011537A (es) | Inhibidores de proteina cinasa. | |
IN2015DN00127A (tr) | ||
RS55746B1 (sr) | Nova pirolopirimidinska jedinjenja kao inhibitori protein kinaza | |
EP2833889A4 (en) | PROTEIN KINASE C HEMMER AND USES THEREOF | |
EP2858501A4 (en) | TRK-A KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF | |
HK1209726A1 (en) | Protein kinase inhibitors | |
HK1205507A1 (en) | Protein kinase inhibitors | |
HK1210036A1 (en) | Aminoisoquinoline derivatives as protein kinase inhibitors | |
EP3042905A4 (en) | Protein kinase inhibitor containing pyrrolopyridazine derivative | |
GB201209458D0 (en) | Novel compounds and their use as kinase inhibitors | |
MY168958A (en) | Intermediates and processes for preparing compounds |